Back to Journals » Lung Cancer: Targets and Therapy » Volume 9

Dramatic response to alectinib in a lung cancer patient with a novel VKORC1L1-ALK fusion and an acquired ALK T1151K mutation

Total article views   Abstract views HTML views PDF downloads Totals
2,494 Dovepress* 1,791 298+ 424 2,089
PubMed Central* 0 405 79 405
Totals 1,791 703 503 2,494
*Since 8 November 2018
+Since July 2016

View citations on PubMed Central and Google Scholar